Evaxion Biotech A/S - ADR

NASDAQ:EVAX   3:59:50 PM EDT
4.08
-0.15 (-3.55%)
Earnings Announcements

Evaxion Biotech Announces Q3 2021 Financial Results

Published: 11/09/2021 11:47 GMT
Evaxion Biotech A/S - ADR (EVAX) - Evaxion Biotech Announces Q3 2021 Financial Results and Provides Business Update.
Q3 Loss per Share $0.27.
Qtrly Cash and Cash Equivalents Were $11.9 Million Compared to $5.8 Million in December 2020.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.31

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.33

More details on our Analysts Page.